I want to talk about something that doesn’t get discussed enough in healthcare… the actual economics of value-based care. Not the theory. Not the policy talking points. The real, operational reality of where organizations make money and where they lose it.

I’ve spent over a decade in VBC operations — across Medicare, Medicare Advantage, and commercial contracts. I’ve sat in the rooms where the financial results come in. Some of those conversations were great. Some of them were brutal. And the pattern I’ve seen is pretty consistent.

One Thing to Get Out of the Way First

VBC economics are not static. The models are always changing. CMS releases new rules, adjusts benchmarks, introduces new programs, sunsets old ones. The payment mechanisms in ACO REACH look different from MSSP. Commercial VBC contracts have their own logic entirely. And within each of those, the specifics of your contract — your risk corridors, your quality multipliers, your attribution methodology — drive a lot of the math.

So I’m not going to pretend there’s a universal formula here. There isn’t. But what I will say is this… the operational fundamentals that determine whether you make or lose money in VBC are remarkably consistent regardless of which model you’re in. The contract structure changes. The playbook for winning doesn’t change nearly as much as people think.

It’s Not Just About Reducing Cost

A common misconception is that VBC is primarily about spending less. That’s only part of it. The real goal is managing total cost of care while improving outcomes and capturing the performance-based revenue that’s tied to quality and risk.

A lot of organizations focus on surface-level metrics — they’ll track their shared savings number or their quality scores — but they don’t always connect those results back to the operational behavior that’s driving them. So they can’t explain why they’re performing well in one area and losing money in another. That’s a problem… because if you can’t diagnose it, you definitely can’t fix it.

Where the Money Is Actually Made

In my experience, most of the financial upside in VBC comes from a few core areas — and they’re the same areas whether you’re in a Medicare model or a commercial arrangement.

The first is accurate risk documentation. When your patient population is documented and coded correctly, you receive appropriate compensation for the complexity you’re actually managing. If risk is under-documented — and it almost always is — you’re leaving money on the table even if the care you’re delivering is excellent.

The second is reducing avoidable utilization. Preventable ED visits, unnecessary admissions, readmissions — these are the highest-cost events in VBC and the ones that swing your financials the most. When high-risk patients are identified early and managed proactively, total cost of care drops. That’s not theory. That’s math.

The third is quality measure performance. Most VBC contracts tie bonuses or incentive pools to specific quality outcomes. Hitting those consistently requires disciplined workflows and reliable follow-through… not just at the clinical level, but operationally. The teams that treat quality reporting as an afterthought always underperform financially.

And the fourth — and this one is personal to me — is attribution. If your patient attribution is inaccurate or constantly shifting, you lose visibility into your true performance. You could be delivering great care and still show poor results because the patients you’re being measured on aren’t the ones you’re actually managing. I’ve called attribution the front door to everything in VBC, and I’ll keep saying it. If you get this wrong, nothing downstream works the way it should.

Where the Money Gets Lost

Just as the upside is predictable, so is the downside.

Poor care coordination is one of the biggest culprits. When patients move between providers without clear communication or follow-up, you get duplicated services, missed interventions, and higher utilization. Nobody planned for that cost. It just happens because the handoff wasn’t clean.

Inconsistent documentation is another one… and it’s probably the most overlooked source of financial leakage in VBC. If clinical complexity isn’t captured accurately, you’re being underpaid relative to the actual risk you’re managing. I’ve seen organizations lose significant revenue not because they were delivering bad care, but because they weren’t documenting the care they were delivering.

Inefficient workflows cost money too. If your teams are spending too much time on administrative work or don’t have clear processes for managing high-risk patients, you’re burning resources without moving the needle on outcomes. In VBC, inefficiency isn’t just an operational issue. It’s a financial one.

And finally — lack of real-time visibility. When you’re only reviewing performance after the fact, you’re missing the window to intervene. By the time the monthly report lands, the avoidable admission already happened. The care gap already widened. The money is already gone.

Operations Drive Economics

This is the part I really want to emphasize. Financial outcomes in VBC are a direct reflection of operational discipline. Period.

If your workflows are inconsistent, your documentation is incomplete, or your care coordination is fragmented… your financials will reflect that. Every time. On the other hand, organizations that build structured processes around high-risk patient management, standardized care pathways, and consistent documentation tend to perform better financially. Not because they’re chasing revenue. Because they’re executing care more effectively.

That’s where operations and economics intersect. Strong operations create predictable outcomes. Predictable outcomes create financial stability in your VBC contracts, regardless of how those contracts are structured.

Data Has to Lead to Action

Data is the foundation of understanding where money is being made or lost. But having data and using data are two very different things.

The best-performing organizations I’ve worked with use data to identify high-risk patients, monitor utilization trends, track quality performance, and evaluate financial exposure — ideally in something close to real-time. That’s what allows them to shift from reactive to proactive.

But data alone isn’t enough. It has to be translated into action. I’ve seen plenty of organizations with great dashboards and beautiful reports that still can’t tell you what to do on Monday morning. The gap between insight and action is where financial performance is won or lost.

Focus Where It Matters

Not every patient, process, or initiative carries equal financial impact. Organizations that try to do everything tend to dilute their effectiveness.

The ones that win focus on the areas that drive the most value — high-risk patients, high-cost utilization patterns, and the specific quality measures that directly impact their shared savings or bonus structures. Concentrated effort on the right levers beats scattered effort across everything.

The Bottom Line

The economics of VBC are complex, and the models will keep evolving. But the fundamentals are consistent. Accurate risk documentation, proactive utilization management, quality performance, clean attribution, and operational discipline — those are the levers that determine whether an organization makes money or loses it.

The organizations that win aren’t necessarily the ones with the most resources or the most advanced technology. They’re the ones that understand how their operations translate into financial performance and build systems that consistently execute on that understanding.

VBC is an operational model with financial consequences. When you align care delivery, data, and workflows around that reality, you put yourself in a position to win regardless of what the next CMS rule change looks like.